Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check5 days agoChange DetectedRevision updated to v3.3.4. Related topics Melanoma and MedlinePlus Genetics, as well as Revision: v3.3.3, were removed.SummaryDifference0.2%

- Check12 days agoChange DetectedAdded Melanoma and MedlinePlus Genetics as related topic links on the page to provide quick access to disease-related resources without altering core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoChange DetectedRemoved Melanoma, related topics, and MedlinePlus Genetics from the page. This reduces the contextual references for the trial.SummaryDifference0.2%

- Check26 days agoChange DetectedMelanoma and related topics: MedlinePlus Genetics were added to the page. The revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure link was removed.SummaryDifference0.3%

- Check34 days agoChange DetectedThe study page no longer displays the disease label 'Melanoma' and the related topics link 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check41 days agoChange DetectedMelanoma and related topics such as MedlinePlus Genetics were added as related topics on the page.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.